CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy SENIOR VICE PRESIDENT AND CMO bought 8,000 shares at $0.50 ($4,000)
- 4 Open-market buy CHAIRMAN, CEO AND PRESIDENT bought 20,000 shares at $0.44 ($8,866)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHAIRMAN, CEO AND PRESIDENT bought 7,000 shares at $0.74 ($5,179)
- 4 Open-market buy Senior Vice President and CFO bought 1,000 shares at $0.70 ($700)
- 4 Open-market buy Senior Vice President and CFO bought 10,000 shares at $0.71 ($7,119)
- 4 Open-market buy Chairman, CEO and President bought 10,000 shares at $0.73 ($7,269)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 18 · 344 filings